4//SEC Filing
Urist Marshall 4
Accession 0001802768-25-000031
CIK 0001802768other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:07 PM ET
Size
5.5 KB
Accession
0001802768-25-000031
Insider Transaction Report
Form 4
Urist Marshall
EVP, Research & Investments
Transactions
- Award
Class A Ordinary Shares
2025-05-08+36,484→ 83,151 total
Holdings
- 19,020(indirect: By IRA)
Class A Ordinary Shares
Footnotes (1)
- [F1]Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001838139
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 5:07 PM ET
- Size
- 5.5 KB